Follow-up of patients diagnosed with polycythemia vera secondary myelofibrosis patients may be orally Lo imatinib October, blood count, spleen size, MPN100 changes in scores and adverse reactions.
Follow-up 1 patient diagnosed with secondary bone marrow fibrosis of true erythinosis orally reedinib in October, observed changes in blood routine, spleen size, MPN100 score and adverse reactions.
One patient with myelofibrosis secondary to polycythemia vera was followed up for 10 months. The changes of blood routine, spleen size, mpn100 score and adverse reactions were observed.